BONNEY MICHAEL W - Insider Transactions
Insider Type
individual
Companies
1
Average
877,295
Total Txns
16
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 1 | -1 | 0.00 | 5,850,000.00 | -5,850,000.00 |
| 2025 | 0 | 15 | -15 | 0.00 | 8,186,716.94 | -8,186,716.94 |
| Total: | 0 | 16 | 10 | 0.00 | 14,036,716.94 | -14,036,716.94 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
450.00 USD |
11,250 Sold |
5,062,500 USD |
18/08/2025 | 18/08/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
271.68 USD |
431 Sold |
117,094 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
277.16 USD |
1,263 Sold |
350,053 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
278.01 USD |
1,239 Sold |
344,454 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
275.63 USD |
301 Sold |
82,965 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
269.79 USD |
245 Sold |
66,099 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
273.16 USD |
660 Sold |
180,286 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
280.03 USD |
432 Sold |
120,973 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
267.14 USD |
549 Sold |
146,660 USD |
15/05/2025 | 15/05/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
268.56 USD |
729 Sold |
195,780 USD |
15/05/2025 | 15/05/2025 |